Wilmington Savings Fund Society FSB Has $5.33 Million Stake in Colgate-Palmolive (NYSE:CL)

Wilmington Savings Fund Society FSB lifted its stake in Colgate-Palmolive (NYSE:CL - Free Report) by 125.0% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 51,333 shares of the company's stock after purchasing an additional 28,518 shares during the period. Wilmington Savings Fund Society FSB's holdings in Colgate-Palmolive were worth $5,329,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. State Street Corp lifted its holdings in Colgate-Palmolive by 3.8% during the 3rd quarter. State Street Corp now owns 48,436,276 shares of the company's stock worth $5,028,170,000 after buying an additional 1,784,411 shares during the last quarter. Geode Capital Management LLC increased its position in Colgate-Palmolive by 2.8% in the 3rd quarter. Geode Capital Management LLC now owns 20,193,331 shares of the company's stock valued at $2,095,325,000 after acquiring an additional 552,949 shares during the period. Massachusetts Financial Services Co. MA increased its position in Colgate-Palmolive by 6.2% in the 3rd quarter. Massachusetts Financial Services Co. MA now owns 9,526,990 shares of the company's stock valued at $988,997,000 after acquiring an additional 557,492 shares during the period. Legal & General Group Plc increased its position in Colgate-Palmolive by 0.8% in the 2nd quarter. Legal & General Group Plc now owns 7,785,101 shares of the company's stock valued at $755,465,000 after acquiring an additional 61,413 shares during the period. Finally, Barclays PLC increased its position in Colgate-Palmolive by 38.7% in the 3rd quarter. Barclays PLC now owns 7,644,189 shares of the company's stock valued at $793,542,000 after acquiring an additional 2,132,747 shares during the period. 80.41% of the stock is currently owned by hedge funds and other institutional investors.

Colgate-Palmolive Stock Performance

Shares of CL traded down $0.09 during midday trading on Friday, reaching $93.47. The stock had a trading volume of 1,418,075 shares, compared to its average volume of 4,366,039. The firm has a 50 day simple moving average of $95.84 and a 200-day simple moving average of $98.58. The company has a current ratio of 1.04, a quick ratio of 0.68 and a debt-to-equity ratio of 9.46. The firm has a market cap of $76.37 billion, a PE ratio of 26.81, a P/E/G ratio of 3.31 and a beta of 0.43. Colgate-Palmolive has a one year low of $75.50 and a one year high of $109.30.

Colgate-Palmolive Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, February 14th. Shareholders of record on Tuesday, January 21st will be paid a $0.50 dividend. This represents a $2.00 annualized dividend and a yield of 2.14%. The ex-dividend date is Tuesday, January 21st. Colgate-Palmolive's dividend payout ratio (DPR) is 57.31%.

Insiders Place Their Bets

In other Colgate-Palmolive news, CFO Stanley J. Sutula III sold 45,410 shares of the firm's stock in a transaction dated Tuesday, November 5th. The shares were sold at an average price of $94.11, for a total value of $4,273,535.10. Following the transaction, the chief financial officer now directly owns 36,726 shares of the company's stock, valued at $3,456,283.86. This trade represents a 55.29 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Corporate insiders own 0.34% of the company's stock.

Analyst Ratings Changes

A number of brokerages have weighed in on CL. JPMorgan Chase & Co. lifted their price objective on Colgate-Palmolive from $113.00 to $114.00 and gave the company an "overweight" rating in a report on Friday, October 11th. TD Cowen dropped their price objective on Colgate-Palmolive from $115.00 to $110.00 and set a "buy" rating for the company in a report on Monday, October 28th. StockNews.com upgraded Colgate-Palmolive from a "hold" rating to a "buy" rating in a report on Monday, November 25th. Wells Fargo & Company dropped their price objective on Colgate-Palmolive from $100.00 to $92.00 and set an "underweight" rating for the company in a report on Monday, October 28th. Finally, Deutsche Bank Aktiengesellschaft downgraded Colgate-Palmolive from a "buy" rating to a "hold" rating and increased their price target for the company from $107.00 to $109.00 in a report on Monday, September 9th. One investment analyst has rated the stock with a sell rating, nine have assigned a hold rating and thirteen have assigned a buy rating to the stock. According to data from MarketBeat, the stock presently has an average rating of "Moderate Buy" and a consensus target price of $105.11.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.